放射状血流信号:甲状腺癌的一种超声新特征
该回顾性多中心研究纳入2018至2022年4家医院的2475例患者共3187个甲状腺结节,评估放射状血流信号对良恶性鉴别的诊断价值。放射状血流信号是诊断甲状腺癌的独立危险因素,将其与ACR TI-RADS评分联合构建的模型在训练集、两个内部验证集和外部验证集中的AUC均显著高于单用ACR TI-RADS评分。
要点
- 放射状血流信号是诊断甲状腺癌的独立危险因素。
- 放射状血流信号联合ACR TI-RADS评分可显著提高诊断效能。
- 联合模型在训练集AUC为0.95,高于ACR TI-RADS评分的0.91。
核心结论
- 放射状血流是甲状腺癌的一种超声新特征,与ACR TI-RADS评分联合可显著提高诊断效能。
研究设计与样本
- 回顾性连续纳入2018至2022年4家医院接受超声检查的患者2475例(女1818例,年龄42.47±11.57岁;男657例,年龄42.16±11.69岁),共3187个结节(恶性2342个,良性845个)。
- 在训练数据集中用多变量逻辑回归分析超声特征与恶性甲状腺结节的相关性。
- 构建包含ACR TI-RADS评分、放射状血流信号及其联合的多变量逻辑回归模型,并进行内部和外部验证。
关键影像表现/征象
- 放射状血流信号是诊断甲状腺癌的独立危险因素。
诊断标准与关键数值
- 训练集中联合模型(放射状血流信号+ACR TI-RADS评分)AUC为0.95(95%CI:0.94,0.97;P<0.001),显著高于ACR TI-RADS模型AUC 0.91(95%CI:0.89,0.93)。
- 两个内部验证集中联合模型AUC分别为0.97(95%CI:0.96,0.98)和0.92(95%CI:0.88,0.96),均显著高于ACR TI-RADS评分的0.92(95%CI:0.90,0.95)和0.86(95%CI:0.81,0.91)(P<0.001)。
- 外部验证集中联合模型AUC为0.91(95%CI:0.86,0.95),显著高于ACR TI-RADS评分的0.84(95%CI:0.79,0.89)(P<0.001)。
临床应用与阅片要点
- 原文结论认为放射状血流是甲状腺癌的超声新特征,与ACR TI-RADS评分联合可显著提高诊断效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To summary radiating blood flow signals and evaluate their diagnostic value in differentiating benign and malignant thyroid nodules.
MATERIALS AND METHODS: We retrospectively recruited consecutive patients undergoing US at 4 hospitals from 2018 to 2022. In a training dataset, the correlations of US features with malignant thyroid nodules were assessed by multivariate logistic analysis. Multivariate logistic regression models involving the ACR TI-RADS score, radiating blood flow signals and their combination were built and validated internally and externally. The AUC with 95% asymptotic normal confidence interval as well as sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) with 95% exact binomial confidence intervals were calculated.
RESULTS: Among 2475 patients (1818 women, age: 42.47 ± 11.57; 657 men, age: 42.16 ± 11.69), there were 3187 nodules (2342 malignant nodules and 845 benign nodules). Radiating blood flow signals were an independent risk factor for diagnosing thyroid carcinoma. In the training set, the AUC of the model using the combination of radiating blood flow signals and the ACR TI-RADS score (0.95 95 % CI: [0.94, 0.97]; P < 0.001) was significantly higher than that of the ACR TI-RADS model (0.91 [0.89, 0.93]). In the two internal validation sets and the external validation set, the AUCs of the combination model were 0.97 [0.96, 0.98], 0.92 [0.88, 0.96], and 0.91 [0.86, 0.95], respectively, and were all significantly higher than that of the ACR TI-RADS score (0.92 [0.90, 0.95], 0.86 [0.81, 0.91], 0.84 [0.79, 0.89]; P < 0.001).
CONCLUSION: Radiating blood flow is a new US feature of thyroid carcinomas that can significantly improve the diagnostic performance vs. the ACR TI-RADS score.
引用
- Huang SS, Yang Z, Li B, et al. Radiating blood flow signal: A new ultrasound feature of thyroid carcinoma. Eur J Radiol. 2024. PMID: 38759544. doi:10.1016/j.ejrad.2024.111502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。